R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2019. CA Cancer J. Clin. 69(1), 7–34 (2019)

Article  PubMed  Google Scholar 

H. Lim, S.S. Devesa, J.A. Sosa, D. Check, C.M. Kitahara, Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13), 1338–1348 (2017)

Article  PubMed  PubMed Central  Google Scholar 

P.I. Haigh, P.H. Ituarte, H.S. Wu, P.A. Treseler, M.D. Posner, J.M. Quivey, Q.Y. Duh, O.H. Clark, Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91(12), 2335–2342 (2001)

Article  PubMed  CAS  Google Scholar 

K.C. Bible, E. Kebebew, J. Brierley, J.P. Brito, M.E. Cabanillas, T.J. Clark Jr., A. Di Cristofano, R. Foote, T. Giordano, J. Kasperbauer, K. Newbold, Y.E. Nikiforov, G. Randolph, M.S. Rosenthal, A.M. Sawka, M. Shah, A. Shaha, R. Smallridge, C.K. Wong-Clark, 2021 American Thyroid Association Guidelines for management of patients with anaplastic thyroid cancer. Thyroid 31(3), 337–386 (2021)

Article  PubMed  PubMed Central  Google Scholar 

E. Molinaro, C. Romei, A. Biagini, E. Sabini, L. Agate, S. Mazzeo, G. Materazzi, S. Sellari-Franceschini, A. Ribechini, L. Torregrossa, F. Basolo, P. Vitti, R. Elisei, Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat. Rev. Endocrinol. 13(11), 644–660 (2017)

Article  PubMed  CAS  Google Scholar 

E. Brignardello, N. Palestini, F. Felicetti, A. Castiglione, A. Piovesan, M. Gallo, M. Freddi, U. Ricardi, G. Gasparri, G. Ciccone, E. Arvat, G. Boccuzzi, Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012. Thyroid 24(11), 1600–1606 (2014)

Article  PubMed  Google Scholar 

R.C. Smallridge, J.A. Copland, Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin. Oncol. (R. Coll. Radio). 22(6), 486–497 (2010)

Article  CAS  Google Scholar 

D.Y. Lee, J.K. Won, S.H. Lee, D.J. Park, K.C. Jung, M.W. Sung, H.G. Wu, K.H. Kim, Y.J. Park, J.H. Hah, Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma. Thyroid 26(3), 404–413 (2016)

Article  PubMed  Google Scholar 

E. Kebebew, F.S. Greenspan, O.H. Clark, K.A. Woeber, A. McMillan, Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 103(7), 1330–1335 (2005)

Article  PubMed  Google Scholar 

M. Kihara, A. Miyauchi, A. Yamauchi, H. Yokomise, Prognostic factors of anaplastic thyroid carcinoma. Surg. Today 34(5), 394–398 (2004)

Article  PubMed  Google Scholar 

T. Song, L. Chen, H. Zhang, Y. Lu, K. Yu, W. Zhan, M. Fang, Multimodal treatment based on thyroidectomy improves survival in patients with metastatic anaplastic thyroid carcinoma: a SEER analysis from 1998 to 2015. Gland Surg. 9(5), 1205–1213 (2020)

Article  PubMed  PubMed Central  Google Scholar 

W. Gui, W. Zhu, W. Lu, C. Shang, F. Zheng, X. Lin, H. Li, Development and validation of a prognostic nomogram to predict overall survival and cancer-specific survival for patients with anaplastic thyroid carcinoma. PeerJ 8, e9173 (2020)

Article  PubMed  PubMed Central  Google Scholar 

A.M. Roche, S.A. Fedewa, L.L. Shi, A.Y. Chen, Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer. Cancer 124(8), 1780–1790 (2018)

Article  PubMed  Google Scholar 

I. Sugitani, A. Miyauchi, K. Sugino, T. Okamoto, A. Yoshida, S. Suzuki, Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J. Surg. 36(6), 1247–1254 (2012)

Article  PubMed  Google Scholar 

N.S. Huang, X. Shi, B.W. Lei, W.J. Wei, Z.W. Lu, P.C. Yu, Y. Wang, Q.H. Ji, Y.L. Wang, An update of the appropriate treatment strategies in anaplastic thyroid cancer: a population-based study of 735 patients. Int J. Endocrinol. 2019, 8428547 (2019)

Article  PubMed  PubMed Central  Google Scholar 

S. Tian, J.M. Switchenko, T. Fei, R.H. Press, M. Abugideiri, N.F. Saba, T.K. Owonikoko, A.Y. Chen, J.J. Beitler, W.J. Curran, T.W. Gillespie, K.A. Higgins. Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: propensity score matched analysis with multiple subgroups. Head Neck. 42, 678–687 (2020)

A.T. Swaak-Kragten, J.H. de Wilt, P.I. Schmitz, M. Bontenbal, P.C. Levendag, Multimodality treatment for anaplastic thyroid carcinoma–treatment outcome in 75 patients. Radiother. Oncol. 92(1), 100–104 (2009)

Article  PubMed  Google Scholar 

S. Filetti, C. Durante, D. Hartl, S. Leboulleux, L.D. Locati, K. Newbold, M.G. Papotti, A. Berruti, Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30(12), 1856–1883 (2019)

Article  PubMed  CAS  Google Scholar 

D. Oliinyk, T. Augustin, J. Rauch, V.F. Koehler, C. Belka, C. Spitzweg, L. Käsmann, Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study. J. Cancer Res Clin. Oncol. 149(7), 3527–3547 (2023)

Article  PubMed  Google Scholar 

W. Zhou, Y. Yue, X. Zhang, Radiotherapy plus chemotherapy leads to prolonged survival in patients with anaplastic thyroid cancer compared with radiotherapy alone regardless of surgical resection and distant metastasis: a retrospective population study. Front. Endocrinol. 12, 748023 (2021)

Article  Google Scholar 

S.K. Yoo, Y.S. Song, E.K. Lee, J. Hwang, H.H. Kim, G. Jung, Y.A. Kim, S.J. Kim, S.W. Cho, J.K. Won, E.J. Chung, J.Y. Shin, K.E. Lee, J.I. Kim, Y.J. Park, J.S. Seo, Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer. Nat. Commun. 10(1), 2764 (2019)

Article  PubMed  PubMed Central  Google Scholar 

V. Subbiah, R.J. Kreitman, Z.A. Wainberg, J.Y. Cho, J.H.M. Schellens, J.C. Soria, P.Y. Wen, C. Zielinski, M.E. Cabanillas, G. Urbanowitz, B. Mookerjee, D. Wang, F. Rangwala, B. Keam, Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer. J. Clin. Oncol. 36(1), 7–13 (2018)

Article  PubMed  CAS  Google Scholar 

L.J. Wirth, M.S. Brose, E.J. Sherman, L. Licitra, M. Schlumberger, S.I. Sherman, K.C. Bible, B. Robinson, P. Rodien, Y. Godbert, C. De La Fouchardiere, K. Newbold, C. Nutting, S. Misir, R. Xie, A. Almonte, W. Ye, M.E. Cabanillas, Open-label, single-arm, multicenter, phase II trial of lenvatinib for the treatment of patients with anaplastic thyroid cancer. J. Clin. Oncol. 39, 2359–2366 (2021)

M.E. Cabanillas, R. Ferrarotto, A.S. Garden, S. Ahmed, N.L. Busaidy, R. Dadu, M.D. Williams, H. Skinner, G.B. Gunn, H. Grosu, P. Iyer, M.C. Hofmann, M. Zafereo, Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Thyroid 28(7), 945–951 (2018)

Article  PubMed  PubMed Central  Google Scholar